$48.7 billion for the National Institutes of Health (NIH), a $400 million increase for the largest source of lupus research funding in the world. The bill also provides a $30 million increase in ...

The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

There are multiple chapters near you. Select your preferred chapter. Supporting lupus patients and advocates in Arizona. Fill ...

A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in people with lupus nephritis, (LN, lupus-related kidney disease).

The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of ...

Listen to this episode of our podcast, The Expert Series. In this month’s episode, we learn more about visible symptoms of lupus with Dr. May Choi.

The Lupus & You: Empowerment conference is an experience that celebrates, inspires, supports, and uplifts lupus warriors, care partners, family, and friends. During this empowering day, attendees will ...

Download a guide explaining what health insurance is and how getting the right health insurance can help with managing lupus.

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle intervention for people with systemic lupus erythematosus (SLE).

Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...

The New England Journal of Medicine has published a detailed analysis of Genentech’s positive results from the Phase III REGENCY study of Gazyva® (Obinutuzumab) for people with active lupus nephritis ...